These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19956900)

  • 1. Isolation of novel cell-penetrating peptides from a random peptide library using in vitro virus and their modifications.
    Kamide K; Nakakubo H; Uno S; Fukamizu A
    Int J Mol Med; 2010 Jan; 25(1):41-51. PubMed ID: 19956900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Creation of a novel cell penetrating peptide, using a random 18mer peptides library.
    Nomura T; Kawamura M; Shibata H; Abe Y; Ohkawa A; Mukai Y; Sugita T; Imai S; Nagano K; Okamoto T; Tsutsumi Y; Kamada H; Nakagawa S; Tsunoda S
    Pharmazie; 2007 Aug; 62(8):569-73. PubMed ID: 17867548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tat(48-60) peptide amino acid sequence is not unique in its cell penetrating properties and cell-surface glycosaminoglycans inhibit its cellular uptake.
    Subrizi A; Tuominen E; Bunker A; Róg T; Antopolsky M; Urtti A
    J Control Release; 2012 Mar; 158(2):277-85. PubMed ID: 22100438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of platelet activation by peptide analogs of the beta(3)-intracellular domain of platelet integrin alpha(IIb)beta(3) conjugated to the cell-penetrating peptide Tat(48-60).
    Dimitriou AA; Stathopoulos P; Mitsios JV; Sakarellos-Daitsiotis M; Goudevenos J; Tsikaris V; Tselepis AD
    Platelets; 2009 Dec; 20(8):539-47. PubMed ID: 19863457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular transduction using cell-penetrating peptides.
    Sawant R; Torchilin V
    Mol Biosyst; 2010 Apr; 6(4):628-40. PubMed ID: 20237640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of in vitro toxicity of five cell-penetrating peptides by metabolic profiling.
    Kilk K; Mahlapuu R; Soomets U; Langel U
    Toxicology; 2009 Nov; 265(3):87-95. PubMed ID: 19799958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
    Youngblood DS; Hatlevig SA; Hassinger JN; Iversen PL; Moulton HM
    Bioconjug Chem; 2007; 18(1):50-60. PubMed ID: 17226957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of uptake of cell penetrating peptides and their cargoes in permeabilized wheat immature embryos.
    Chugh A; Eudes F
    FEBS J; 2008 May; 275(10):2403-14. PubMed ID: 18397318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transport molecules using reverse sequence HIV-Tat polypeptides: not just any old Tat? (WO200808225).
    Howl J; Jones S
    Expert Opin Ther Pat; 2009 Sep; 19(9):1329-33. PubMed ID: 19555160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of TAT cell membrane penetration efficiency by dimethyl sulphoxide.
    Wang H; Zhong CY; Wu JF; Huang YB; Liu CB
    J Control Release; 2010 Apr; 143(1):64-70. PubMed ID: 20025914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane permeability commonly shared among arginine-rich peptides.
    Futaki S; Goto S; Sugiura Y
    J Mol Recognit; 2003; 16(5):260-4. PubMed ID: 14523938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photo inducible RNA interference using cell permeable protein carrier.
    Endoh T; Sisido M; Ohtsuki T
    Nucleic Acids Symp Ser (Oxf); 2007; (51):127-8. PubMed ID: 18029619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-assembling mini cell-penetrating peptides enter by both direct translocation and glycosaminoglycan-dependent endocytosis.
    Bode SA; Thévenin M; Bechara C; Sagan S; Bregant S; Lavielle S; Chassaing G; Burlina F
    Chem Commun (Camb); 2012 Jul; 48(57):7179-81. PubMed ID: 22692031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides.
    Gupta B; Levchenko TS; Torchilin VP
    Adv Drug Deliv Rev; 2005 Feb; 57(4):637-51. PubMed ID: 15722168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric screening of cell-penetrating peptides for their uptake into embryonic and adult stem cells.
    Manceur A; Wu A; Audet J
    Anal Biochem; 2007 May; 364(1):51-9. PubMed ID: 17379177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional analysis of backbone cyclic peptides bearing the arm domain of the HIV-1 Rev protein: characterization of the karyophilic properties and inhibition of Rev-induced gene expression.
    Hariton-Gazal E; Rosenbluh J; Zakai N; Fridkin G; Brack-Werner R; Wolff H; Devaux C; Gilon C; Loyter A
    Biochemistry; 2005 Aug; 44(34):11555-66. PubMed ID: 16114892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationships of arodyn, a novel acetylated kappa opioid receptor antagonist.
    Bennett MA; Murray TF; Aldrich JV
    J Pept Res; 2005 Mar; 65(3):322-32. PubMed ID: 15787962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The augmentation of intracellular delivery of peptide therapeutics by artificial protein transduction domains.
    Yoshikawa T; Sugita T; Mukai Y; Abe Y; Nakagawa S; Kamada H; Tsunoda S; Tsutsumi Y
    Biomaterials; 2009 Jul; 30(19):3318-23. PubMed ID: 19304319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlling human immunodeficiency virus type 1 gene expression by unnatural peptides.
    Huq I; Ping YH; Tamilarasu N; Rana TM
    Biochemistry; 1999 Apr; 38(16):5172-7. PubMed ID: 10213623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the use of cell-penetrating peptides for medical and biological applications.
    Fonseca SB; Pereira MP; Kelley SO
    Adv Drug Deliv Rev; 2009 Sep; 61(11):953-64. PubMed ID: 19538995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.